606 related articles for article (PubMed ID: 35995341)
41. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation.
Tuli HS; Sak K; Iqubal A; Garg VK; Varol M; Sharma U; Chauhan A; Yerer MB; Dhama K; Jain M; Jain A
Mol Biol Rep; 2022 Sep; 49(9):8987-8999. PubMed ID: 35474053
[TBL] [Abstract][Full Text] [Related]
42. Activation of STAT proteins and growth control.
Bromberg JF
Bioessays; 2001 Feb; 23(2):161-9. PubMed ID: 11169589
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells.
Lee MY; Joung YH; Lim EJ; Park JH; Ye SK; Park T; Zhang Z; Park DK; Lee KJ; Yang YM
Breast; 2006 Apr; 15(2):187-95. PubMed ID: 16084091
[TBL] [Abstract][Full Text] [Related]
44. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
45. STAT Signaling in Glioma Cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
[TBL] [Abstract][Full Text] [Related]
46. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
[TBL] [Abstract][Full Text] [Related]
47. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.
Wang LL; Wan XY; Liu CQ; Zheng FM
Mol Med; 2022 May; 28(1):49. PubMed ID: 35508987
[TBL] [Abstract][Full Text] [Related]
48. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
49. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
50. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
51. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.
Zhu Z; Yuan J; Xu X; Wei Y; Yang B; Zhao H
Neoplasia; 2021 Jan; 23(1):36-48. PubMed ID: 33217668
[TBL] [Abstract][Full Text] [Related]
52. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
53. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
[TBL] [Abstract][Full Text] [Related]
54. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
Aggarwal BB; Kunnumakkara AB; Harikumar KB; Gupta SR; Tharakan ST; Koca C; Dey S; Sung B
Ann N Y Acad Sci; 2009 Aug; 1171():59-76. PubMed ID: 19723038
[TBL] [Abstract][Full Text] [Related]
55. The role of STATs in inflammation and inflammatory diseases.
Pfitzner E; Kliem S; Baus D; Litterst CM
Curr Pharm Des; 2004; 10(23):2839-50. PubMed ID: 15379672
[TBL] [Abstract][Full Text] [Related]
56. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
57. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
58. Signal transducer and activator of transcription proteins in leukemias.
Benekli M; Baer MR; Baumann H; Wetzler M
Blood; 2003 Apr; 101(8):2940-54. PubMed ID: 12480704
[TBL] [Abstract][Full Text] [Related]
59. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.
Bartucci M; Dattilo R; Moriconi C; Pagliuca A; Mottolese M; Federici G; Benedetto AD; Todaro M; Stassi G; Sperati F; Amabile MI; Pilozzi E; Patrizii M; Biffoni M; Maugeri-Saccà M; Piccolo S; De Maria R
Oncogene; 2015 Feb; 34(6):681-90. PubMed ID: 24531710
[TBL] [Abstract][Full Text] [Related]
60. Targeting the JAK/STAT Signaling Pathway for Breast Cancer.
Shao F; Pang X; Baeg GH
Curr Med Chem; 2021; 28(25):5137-5151. PubMed ID: 33290193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
